Analysts Piper Sandler upgrade Rivian (RIVN) and Mobileye (MBLY) to Overweight, citing strong demand outlooks

Piper Sandler upgraded Rivian and Mobileye to overweight, citing a de-risked balance sheet and improved demand outlook for Rivian, while Mobileye is seen as nearing a floor valuation. Additionally, Piper initiated coverage of Williams-Sonoma with an overweight rating and a price target of $253, highlighting its strong EBIT margin in a challenging home furnishing market.

JPMorgan initiated coverage of Rhythm Pharmaceuticals with an overweight rating and a price target of $145, indicating significant growth potential. Citizens rated Sonida Senior Living as market outperform, with a price target of $50, reflecting its attractiveness to institutional investors.

Roth initiated Aduro Clean Technologies as a buy, with a price target of $30, due to its innovative recycling technology. UBS upgraded Cameco to buy, suggesting a favorable entry point following recent stock declines. Jefferies upgraded both General Motors and Ford to buy, citing robust free cash flow and a potential recovery in production volumes, respectively.

Other notable mentions include Goldman Sachs initiating coverage of Neutron Holdings and Bending Spoons as buys, and Morgan Stanley initiating Somnigroup as overweight, emphasizing its competitive advantages. Conversely, Barclays downgraded Anheuser-Busch InBev to equal weight, citing negative catalysts affecting its earnings outlook.

Overall, these analyst calls reflect a mix of optimism and caution across different sectors, providing investors with insights into potential opportunities and risks

Stocks in this article

Company Price Change Change % AI
Mobileye Global MBLY.US 8.61 +0.56 +6.96% Sell
Rivian RIVN.US 16.36 +0.52 +3.28% Sell
Cameco CCJ.US 90.70 +2.84 +3.23% Sell
General Motors GM.US 85.29 +2.64 +3.20% Hold
Ford Motor Company F.US 14.74 +0.39 +2.72% Sell
Williams-Sonoma WSM.US 232.84 +6.10 +2.69% Hold
Anheuser-Busch InBev BUD.US 80.42 -1.24 -1.52% Hold

More investing news